Teresa Ramirez Montagut

Summary

Affiliation: The Rockefeller University
Country: USA

Publications

  1. ncbi Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity
    Teresa Ramirez-Montagut
    Department of Medicine and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Immunol 176:6434-42. 2006
  2. ncbi IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease
    Teresa Ramirez-Montagut
    Department of Immunology, Laboratory of the Immunology of Bone Marrow Transplantation, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Immunol 179:1669-80. 2007
  3. ncbi GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease
    Stephanie J Muriglan
    Department of Medicine and Immunology, Memorial Sloan Kettering Cancer Center, Kettering 425, Mailbox 111, 1275 York Ave, New York, NY 10021, USA
    J Exp Med 200:149-57. 2004
  4. ncbi CCR2 is required for CD8-induced graft-versus-host disease
    Theis H Terwey
    Department of Medicine and Immunology, Memorial Sloan Kettering Cancer Center, Kettering 406D, Mailbox 111, 1275 York Ave, New York, NY 10021, USA
    Blood 106:3322-30. 2005
  5. ncbi Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains
    Cristina R Ferrone
    The Swim Across America Laboratory, Memorial Sloan-Kettering Cancer Center, Weill Medical and Graduate Schools of Cornell University, New York, NY 10021, USA
    Clin Cancer Res 12:5511-9. 2006
  6. ncbi Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity
    Teresa Ramirez-Montagut
    Memorial Sloan-Kettering Cancer Center and the Weill Graduate School of Medical Sciences of Cornell University, 1275 York Avenue, New York, NY 10021, USA
    Oncogene 22:3180-7. 2003

Collaborators

  • S Sakaguchi
  • M-A Perales
  • Stacie M Goldberg
  • Teresa Ramirez-Montagut
  • Theis H Terwey
  • Adam A Kochman
  • Marcel R m van den Brink
  • Alan N Houghton
  • Sydney Lu
  • Onder Alpdogan
  • Stephanie J Muriglan
  • Andrew Chow
  • Daniel Hirschhorn-Cymerman
  • George F Murphy
  • Glenn Heller
  • Theo D Kim
  • Chen Liu
  • Cristina R Ferrone
  • Mary Jo Turk
  • Jeffrey M Eng
  • Vanessa M Hubbard
  • Jedd D Wolchok
  • Neel Patel
  • Hamad Sindhi
  • Odette M Smith
  • Jeremy Grubin
  • Chiara Borsotti
  • David Suh
  • C Joy Somberg
  • Randy C Miles
  • Jason S Gold
  • Polly D Gregor
  • Johannes L Zakrzewski
  • Tulin Budak-Alpdogan
  • Thomas W Van Huystee
  • Carlo Riccardi
  • Pier Paolo Pandolfi
  • Kartono H Tjoe

Detail Information

Publications6

  1. ncbi Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity
    Teresa Ramirez-Montagut
    Department of Medicine and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Immunol 176:6434-42. 2006
    ..Thus, we conclude that overall, GITR stimulation overcomes self-tolerance/ignorance and enhances T cell-mediated antitumor activity with minimal autoimmunity...
  2. ncbi IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease
    Teresa Ramirez-Montagut
    Department of Immunology, Laboratory of the Immunology of Bone Marrow Transplantation, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Immunol 179:1669-80. 2007
    ....
  3. ncbi GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease
    Stephanie J Muriglan
    Department of Medicine and Immunology, Memorial Sloan Kettering Cancer Center, Kettering 425, Mailbox 111, 1275 York Ave, New York, NY 10021, USA
    J Exp Med 200:149-57. 2004
    ..Our findings indicate that GITR has opposite effects on the regulation of alloreactive CD4(+) and CD8(+) T cells...
  4. ncbi CCR2 is required for CD8-induced graft-versus-host disease
    Theis H Terwey
    Department of Medicine and Immunology, Memorial Sloan Kettering Cancer Center, Kettering 406D, Mailbox 111, 1275 York Ave, New York, NY 10021, USA
    Blood 106:3322-30. 2005
    ..Interestingly, the graft-versus-tumor effect mediated by CCR2-/- CD8+ T cells was preserved, which suggests that interference with T-cell migration by blockade of CCR2 signaling can separate GVHD from GVT activity...
  5. ncbi Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains
    Cristina R Ferrone
    The Swim Across America Laboratory, Memorial Sloan-Kettering Cancer Center, Weill Medical and Graduate Schools of Cornell University, New York, NY 10021, USA
    Clin Cancer Res 12:5511-9. 2006
    ....
  6. ncbi Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity
    Teresa Ramirez-Montagut
    Memorial Sloan-Kettering Cancer Center and the Weill Graduate School of Medical Sciences of Cornell University, 1275 York Avenue, New York, NY 10021, USA
    Oncogene 22:3180-7. 2003
    ..Vitiligo (autoimmune hypopigmentation) can be mediated by T cells, FcgammaR+macrophages and/or complement...